Invention Grant
- Patent Title: T cell modifying compounds and uses thereof
-
Application No.: US15453603Application Date: 2017-03-08
-
Publication No.: US11236175B2Publication Date: 2022-02-01
- Inventor: Philip D. Gregory , Michael C. Holmes
- Applicant: Sangamo Therapeutics, Inc.
- Applicant Address: US CA Richmond
- Assignee: Sangamo Therapeutics, Inc.
- Current Assignee: Sangamo Therapeutics, Inc.
- Current Assignee Address: US CA Richmond
- Agency: Foley & Lardner LLP
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C07K16/32 ; C07K16/28 ; A61K35/17 ; C12N5/0783 ; A61K48/00 ; C12N5/10 ; A61K35/26
Abstract:
Methods and compositions for modifying T-cells in which PD1 and/or CTLA-4 is repressed and/or inactivated using fusion proteins such as artificial transcription factors and nucleases.
Public/Granted literature
- US20170183420A1 T CELL MODIFYING COMPOUNDS AND USES THEREOF Public/Granted day:2017-06-29
Information query
